Symptoms of Low Black Currant Seed Oil: Causes and Treatment
Deficiency
Symptoms & causes
Black currant seed oil is not an essential nutrient and no recognized clinical deficiency syndrome exists; it is a gamma-linolenic acid (GLA)-rich oil marketed for inflammation and skin health without established deficiency criteria.
You cannot be deficient in black currant seed oil because your body makes its key active component, gamma-linolenic acid (GLA), from dietary linoleic acid. While BCSO is a unique oil that also contains stearidonic acid, the concept of a 'deficiency' is a marketing construct, not a medical diagnosis. The oil has its best evidence for inflammatory joint and skin conditions, not for correcting a nutritional shortfall.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Black currant seed oil (BCSO) — a cold-pressed oil from the seeds of Ribes nigrum; notable for containing both gamma-linolenic acid (GLA, an omega-6 fatty acid) and stearidonic acid (SDA, an omega-3 precursor), distinguishing it from other GLA-containing oils (evening primrose, borage) which lack SDA. GLA is derived from linoleic acid (LA); while LA is an essential fatty acid, GLA itself is synthesized endogenously via the delta-6-desaturase enzyme — so BCSO is not an essential oil.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- No symptoms attributable specifically to low BCSO or GLA intake; no deficiency phenotype has been characterized in humans.
- General essential fatty acid deficiency (LA + ALA) can cause dry scaly skin, hair loss, and impaired wound healing — but this is caused by LA deficiency, not BCSO deficiency specifically.
Don't wait
See a doctor if
- Persistent dry, scaly skin
- Hair loss
- Impaired wound healing
- Growth retardation in children
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No clinical deficiency population for BCSO/GLA exists.
- People with impaired delta-6-desaturase activity (elderly, type 2 diabetics, high-trans-fat diets) may have reduced endogenous GLA synthesis from LA; this is the closest analog to a 'low GLA' population, but it does not constitute a recognized deficiency syndrome.
What causes low Black currant seed oil (BCSO) — a cold-pressed oil from the seeds of Ribes nigrum; notable for containing both gamma-linolenic acid (GLA, an omega-6 fatty acid) and stearidonic acid (SDA, an omega-3 precursor), distinguishing it from other GLA-containing oils (evening primrose, borage) which lack SDA. GLA is derived from linoleic acid (LA); while LA is an essential fatty acid, GLA itself is synthesized endogenously via the delta-6-desaturase enzyme — so BCSO is not an essential oil.
- Not applicable to true deficiency. Lower GLA intake is associated with reduced BCSO, evening primrose oil, or borage oil consumption, but GLA is synthesized from dietary LA by the delta-6-desaturase enzyme.
- Enzyme activity may be reduced in aging, diabetes, and high saturated fat or trans-fat diets — contexts where GLA synthesis from LA is impaired.
How low levels are diagnosed
No recognized diagnostic test for BCSO or GLA deficiency. Plasma fatty acid profiles can measure GLA and LA levels in research settings but are not a standard clinical workup.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Not applicable for true deficiency. Food sources of GLA: BCSO, evening primrose oil, borage seed oil, spirulina; dietary linoleic acid (sunflower, safflower, soybean oils, nuts, seeds) provides the LA precursor. Supplement doses used in trials: 450–3,000 mg/day GLA from BCSO or evening primrose oil; typical BCSO capsules supply 300–500 mg oil per capsule with roughly 45–100 mg GLA.
How to keep levels up
Not applicable. Adequate dietary LA intake (sunflower/safflower/soybean oils, nuts) supports endogenous GLA synthesis.
When to see a clinician
Not applicable to BCSO deficiency. Seek care for signs of true essential fatty acid deficiency (persistent scaly skin, hair loss, impaired wound healing). If using BCSO supplements: discuss with a clinician if on anticoagulants (GLA may affect platelet aggregation) or before surgery.
Black Currant Seed Oil Is Not a Nutrient You Can Be Deficient In—Here Is Why
The idea that you can walk around with a 'black currant seed oil deficiency' is a marketing invention, not a medical reality. Your body already knows how to make the oil's star component, gamma-linolenic acid (GLA), from the linoleic acid in your diet.
Linoleic acid is an essential omega-6 fatty acid—you must get it from food because your body cannot make it. Once consumed, an enzyme called delta-6-desaturase converts a portion of that linoleic acid into GLA. Because this conversion happens endogenously, GLA itself is not classified as an essential fatty acid, and black currant seed oil is not an essential oil.
No Recommended Dietary Allowance (RDA), Adequate Intake (AI), or Estimated Average Requirement (EAR) has been established for GLA or black currant seed oil by the National Institutes of Health or the Institute of Medicine. The only essential nutrient in this pathway is the parent compound, linoleic acid, which is abundant in sunflower, safflower, and soybean oils, as well as nuts and seeds.
Bottom line
You cannot be clinically deficient in BCSO—the 'deficiency' framing is a marketing construct. The actual essential nutrient in the omega-6 pathway is linoleic acid, which is widely available in common cooking oils and nuts.
What Makes Black Currant Seed Oil Unique: GLA + Stearidonic Acid Together
Black currant seed oil earns its shelf space among fatty acid supplements because of a rare dual profile: it contains both GLA and stearidonic acid. Evening primrose oil and borage oil supply GLA, but they lack SDA entirely.
Stearidonic acid is an omega-3 fatty acid that sits a step closer to EPA than the more common alpha-linolenic acid (ALA) found in flaxseed. The conversion of ALA to EPA in humans is notoriously inefficient—typically in the single digits. SDA bypasses the rate-limiting delta-6-desaturase step in the omega-3 pathway, meaning a greater proportion is converted to EPA in the body.
This dual omega-3 and omega-6 precursor profile is the biochemical basis for BCSO's proposed anti-inflammatory advantage. The GLA arm feeds into dihomo-gamma-linolenic acid (DGLA), which can produce anti-inflammatory eicosanoids, while the SDA arm feeds into the EPA pathway. No other common plant oil offers this combination at meaningful concentrations.
Bottom line
The combination of GLA and SDA is BCSO's main distinguishing feature among plant oils—understanding this helps consumers make an informed choice versus evening primrose oil or borage oil, which supply only GLA.
The Evidence for Black Currant Seed Oil: Inflammation, Skin, and RA
The most credible human trial data for GLA-containing oils—including BCSO, evening primrose oil, and borage oil—comes from rheumatoid arthritis and atopic dermatitis research. In rheumatoid arthritis, several randomized controlled trials have shown that GLA supplementation can reduce morning stiffness and joint tenderness, with some meta-analyses reporting statistically significant though modest effect sizes.
For atopic dermatitis, the evidence is mixed but leans toward a modest benefit for skin barrier function and hydration. The Cochrane Collaboration has reviewed GLA for eczema, noting that while some trials show reduced itching and dryness, the overall evidence base is limited by small sample sizes and short study durations.
Claims for menopausal symptoms, premenstrual syndrome, and general anti-aging effects are substantially weaker. Most trials in these areas are small, often industry-funded, and have not been replicated by independent research groups. The anti-inflammatory mechanism is plausible, but the leap from mechanism to clinical benefit for these conditions outruns the data.
Bottom line
The most credible use case for BCSO/GLA is inflammatory joint conditions and atopic skin conditions; anti-aging, PMS, and general anti-inflammatory claims in healthy adults outrun the trial evidence.
Delta-6-Desaturase Impairment: The Closest Thing to a 'Low GLA' State
While 'GLA deficiency' is not a clinical diagnosis, there are real physiological scenarios where your body's ability to make GLA from linoleic acid is compromised. The enzyme responsible for this conversion, delta-6-desaturase, declines in activity with age and is impaired in type 2 diabetes.
High intake of saturated fat and trans fats can also suppress delta-6-desaturase activity, effectively creating a bottleneck in the conversion of linoleic acid to GLA. In these contexts, the body's endogenous GLA production may fall short of what it could otherwise produce, even when dietary linoleic acid intake is adequate.
This metabolic impairment scenario is the most honest framing for who might benefit from BCSO supplementation. It is not that these individuals have a nutritional deficiency—it is that their enzymatic machinery is less efficient, and providing pre-formed GLA may partially compensate. This is a pharmacological or nutraceutical rationale, not a nutritional correction.
Bottom line
If delta-6-desaturase activity is impaired due to diabetes, aging, or a high trans-fat diet, the body is less efficient at making GLA from LA—this is the closest analog to a 'low GLA' state, though it is not classified as a clinical deficiency.
Black Currant Seed Oil and GLP-1 Therapy: Inflammation, Weight Loss, and Drug Interactions
People using GLP-1 receptor agonists like semaglutide or tirzepatide typically reduce their total caloric and fat intake, which could theoretically lower dietary linoleic acid consumption. However, because linoleic acid is present in so many common foods—including the small amounts of oil used in cooking—a meaningful GLA shortfall is unlikely in most cases.
GLP-1 drugs themselves exert anti-inflammatory effects independent of weight loss, and it is mechanistically plausible that BCSO's GLA could have additive anti-inflammatory action. However, no clinical trials have tested this combination, so any claim of synergy is speculative.
The practical safety consideration for GLP-1 users is the platelet-aggregation effect. GLA may reduce platelet aggregation, and the metabolic-disease population often takes aspirin, clopidogrel, or warfarin. Adding BCSO on top of these medications could theoretically increase bleeding risk. This interaction is rarely flagged in consumer-facing content but is the most clinically relevant point for anyone on polypharmacy.
Bottom line
BCSO has no established role in GLP-1 therapy, and the platelet-aggregation effect is the practical safety consideration for polypharmacy GLP-1 users—discuss with a clinician or pharmacist before adding.
What most pages leave out
Competitor content typically presents BCSO as a broad anti-inflammatory and weight-loss aid. The honest framing: the 'deficiency' premise has no clinical basis; the most credible trial evidence is for inflammatory joint conditions and atopic skin, not weight loss or general wellness; the delta-6-desaturase impairment context is more accurate than 'you're deficient in GLA.' The platelet-aggregation drug interaction is rarely flagged in consumer-facing content.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There are none. Black currant seed oil is not an essential nutrient, and no deficiency syndrome has been defined by any major health authority. The body synthesizes its key fatty acid, GLA, from linoleic acid found in common cooking oils and nuts.
The best clinical evidence supports its use for inflammatory joint conditions like rheumatoid arthritis and for atopic dermatitis. The combination of GLA and stearidonic acid may offer anti-inflammatory advantages over oils that only contain GLA.
Both oils contain GLA, but black currant seed oil also contains stearidonic acid, an omega-3 precursor that converts to EPA more efficiently than the ALA found in flaxseed. This gives BCSO a dual anti-inflammatory fatty acid profile that evening primrose oil lacks.
People with impaired delta-6-desaturase activity—such as those with type 2 diabetes, older adults, or individuals with high trans-fat diets—may benefit most, as their bodies are less efficient at making GLA from dietary linoleic acid. Those with inflammatory joint or skin conditions also represent the primary evidence-based use case.
Clinical trials have used doses supplying 450 to 3,000 mg of GLA per day. Since typical BCSO capsules deliver roughly 45 to 100 mg of GLA each, multiple capsules are often needed to reach the doses studied in research.
GLA may reduce platelet aggregation and could theoretically potentiate the effects of anticoagulant or antiplatelet drugs. If you take aspirin, warfarin, or clopidogrel, discuss BCSO supplementation with a pharmacist or clinician before starting.
No strong clinical trial evidence supports BCSO specifically for weight loss. Its anti-inflammatory properties should not be confused with a direct effect on body weight or fat mass.
No specific interaction with GLP-1 drugs like semaglutide or tirzepatide has been established. However, the potential platelet-aggregation effect and interactions with common medications like blood thinners warrant a conversation with your prescribing clinician.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Coconut Oil: Causes and Treatment
Coconut oil is a dietary fat, not an essential nutrient — no deficiency syndrome exists. Learn why major health authorities recommend limiting its saturated fat content.
Read moreSymptoms of Low Hemp Oil: Causes and Treatment
Hemp oil is a cooking oil, not a nutrient, and no deficiency syndrome exists. Learn the truth about hemp oil vs. CBD oil, its fatty acid profile, and skin health claims.
Read moreSymptoms of Low Flaxseed Oil: Causes, Treatment, and ALA Deficiency
Flaxseed oil provides the essential omega-3 ALA, but true deficiency is rare. Learn the symptoms of low ALA intake, how it compares to fish oil, and proper use.
Read moreSymptoms of Low Cod Liver Oil: Causes and Treatment
There is no cod liver oil deficiency syndrome. Learn about the unique risks of vitamin A toxicity, how it differs from fish oil, and safe dosing practices.
Read moreSymptoms of Low Krill Oil: Causes, Treatment, and the Evidence
Krill oil is not a nutrient — no deficiency syndrome exists. It is an EPA/DHA source in phospholipid form with astaxanthin. Learn the evidence, cost, and GLP-1 context.
Read moreHealthy Recipes for Black Friday: Meal Prep and Leftover Ideas
Smart Black Friday meal prep: high-protein turkey power bowls, packable energy bites, and leftover chili. Practical recipes for a long shopping day without the food court crash.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.